Topic
Pankaj Patel
CSIR-Central Drug Research Institute Lucknow, Zydus to develop drug for chronic kidney disease induced osteoporosis
CDRI and Zydus will jointly undertake preclinical research Based on research conducted at Central Drug Research Institute (CDRI), Lucknow and data from…
Zydus Lifesciences bags approval for ‘Usnoflast’
The approval has been received from the WHO International Non-proprietary Names Zydus, a leading discovery-based, global pharmaceutical company, has received…
IPA releases report on social initiatives
The report seeks to understand the role played and impact created by IPA member companies in nation building through CSR…
Non-Cirrhotic NASH, World’s First Drug Saroglitazar by Zydus Approved
Ahmedabad: Zydus Cadila, an innovation-driven global pharmaceutical company today announced that the Drug Controller General of India (DCGI) has approved…